932368-54-2 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
6-Cinnolinecarboxaldehyde is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals, contributing to the development of new drugs and agricultural products.
Used in Dye and Pigment Production:
6-Cinnolinecarboxaldehyde is utilized in the production of dyes and pigments, providing colorants for various applications in industries such as textiles, plastics, and printing.
Used as a Flavor and Fragrance Ingredient:
6-Cinnolinecarboxaldehyde is employed as a flavor and fragrance ingredient, enhancing the sensory properties of food, beverages, and cosmetics.
Used in Organic Compound Manufacturing:
6-Cinnolinecarboxaldehyde is an important building block in the manufacturing of organic compounds, facilitating the creation of a wide range of chemical products.
Safety Precautions:
It is crucial to handle 6-Cinnolinecarboxaldehyde with care, as it may cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use and storage to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 932368-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,2,3,6 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 932368-54:
(8*9)+(7*3)+(6*2)+(5*3)+(4*6)+(3*8)+(2*5)+(1*4)=182
182 % 10 = 2
So 932368-54-2 is a valid CAS Registry Number.
932368-54-2Relevant articles and documents
THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS
-
, (2008/06/13)
Invented is a method of inhibiting the activity/function of PI3 kinases using substituted thiazolones. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, ne
NOVEL CHEMICAL COMPOUNDS
-
Page/Page column 32-33, (2010/11/26)
This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins.